MCU knockdown mitigates post-stroke neuroinflammation through SLC33A1-mediated reduction of NR4A1 acetylation

Zhou Zhou1, Lijuan Liu1, Yicong Zhou2

  • 1Department of Neurology, The First Hospital of Hebei Medical University, No. 89, Donggang Road, Yuhua District, Shijiazhuang, Hebei 050031, China.

Brain Research Bulletin
|December 6, 2025
PubMed

Insights

Mitochondrial calcium uniporter (MCU) knockdown reduces stroke injury and brain inflammation. This neuroprotective effect is mediated by SLC33A1, which controls NR4A1 acetylation, offering a potential anti-inflammatory therapy for stroke recovery.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Immunology

Background:

  • Post-stroke neuroinflammation exacerbates brain injury and hinders recovery.
  • Mitochondrial calcium uniporter (MCU) knockdown previously showed protection against ischemic injury.
  • Transcriptomic data suggested a role for NR4A1 in MCU-mediated effects.

Purpose of the Study:

  • To elucidate the mechanism by which MCU knockdown confers neuroprotection post-stroke.
  • To investigate the interaction between MCU, NR4A1, and inflammatory pathways in microglia.

Main Methods:

  • Utilized a mouse middle cerebral artery occlusion (MCAO) model for ischemic stroke.
  • Employed microglial oxygen-glucose deprivation/reoxygenation (OGD/R) models.
  • Conducted protein interaction assays (immunoprecipitation-mass spectrometry) and acetylation assays.

Main Results:

  • MCU knockdown significantly reduced infarct volume and improved neurological function in MCAO mice.
  • MCU knockdown suppressed microglial inflammatory cytokine expression.
  • Identified SLC33A1 as a novel MCU interactor, mediating reduced NR4A1 acetylation and attenuated inflammation.

Conclusions:

  • MCU knockdown mitigates cerebral infarction and suppresses microglial inflammation.
  • The mechanism involves SLC33A1-dependent regulation of NR4A1 acetylation.
  • MCU knockdown represents a promising strategy for post-stroke anti-inflammatory intervention.

Related Concept Videos

Ligand-gated Ion Channels01:19

Ligand-gated Ion Channels

Ligand-gated ion channels are transmembrane proteins with a channel for ions to pass through and a binding site for a ligand. The channel opens only when a ligand attaches to the binding site.
Three Subfamilies of Ligand-gated Ion Channels
Ligand-gated ion channels fall into three subfamilies. The 'Cys-loop' includes the nicotinic acetylcholine receptors, γ-aminobutyric acid (GABA), glycine, and 5-hydroxytryptamine receptors. The second one is the 'Pore-loop' channels that...
11.4K
Ligand-Gated Ion Channel Receptor: Gating Mechanism01:30

Ligand-Gated Ion Channel Receptor: Gating Mechanism

Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
4.6K
CNS Depressants: Alcohol and Nicotine01:27

CNS Depressants: Alcohol and Nicotine

Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
1.7K
Esophageal Achalasia01:27

Esophageal Achalasia

Esophageal achalasia is a chronic neurogenic disorder characterized by impaired relaxation of the lower esophageal sphincter (LES) and absent or ineffective peristalsis in the distal esophagus. This leads to a functional obstruction without a physical blockage, despite significant disruption of esophageal motility.EtiologyAchalasia is caused by degeneration of the myenteric (Auerbach's) plexus, specifically the loss of inhibitory ganglion cells that produce vasoactive intestinal peptide...
45